Rift Valley fever
Rift Valley fever (RVF) is a viral disease that primarily affects livestock but can also infect humans. It is transmitted through contact with infected animal blood or organs, or through bites from infected mosquitoes. Symptoms in humans range from mild flu-like illness to severe complications such as hemorrhagic fever. The disease is endemic in parts of Africa and the Arabian Peninsula, with outbreaks often linked to heavy rainfall and flooding. There is no specific treatment, but supportive care can help manage symptoms. Vaccines exist for animals, but human vaccines are not widely available.
Key facts
| Transmission | Contact with infected animal blood or organs, bites from infected mosquitoes. |
|---|---|
| Incubation | 2 to 6 days. |
| Case fatality | Varies; up to 50% in severe cases. |
| Reproduction number | unknown |
| Vaccine | Available for animals; limited availability for humans. |
| Treatment | Supportive care; no specific antiviral treatment. |
| Reservoir | Primarily livestock (e.g., cattle, sheep, goats, camels). |
| Endemic regions | Sub-Saharan Africa, Arabian Peninsula. |
Transmission
Rift Valley fever (RVF) is primarily transmitted to humans through direct contact with the blood, organs, or other bodily fluids of infected animals, such as during slaughtering or veterinary procedures. It can also be transmitted through the bites of infected mosquitoes, which act as vectors for the virus. Consuming unpasteurized or undercooked milk from infected animals is another potential route of transmission. Human-to-human transmission has not been documented.
- Rift Valley fever Wikipedia
- Rift Valley fever- Mauritania and Senegal WHO · 5 Nov 2025
Symptoms and severity
In humans, RVF can cause a range of symptoms. Most cases are mild, presenting as flu-like symptoms such as fever, muscle pain, and headaches. However, in some cases, the disease can progress to more severe forms, including hemorrhagic fever, encephalitis, or ocular disease, which can lead to blindness. The case fatality rate can be as high as 50% in severe cases.
- Rift Valley fever Wikipedia
- Rift Valley fever- Mauritania and Senegal WHO · 5 Nov 2025
Treatment and vaccines
There is no specific antiviral treatment for RVF. Management of the disease in humans is primarily supportive, focusing on alleviating symptoms and preventing complications. Vaccines are available for animals to prevent outbreaks, but human vaccines are not widely available and are generally used in high-risk populations or research settings.
- Rift Valley fever Wikipedia
- Rift Valley fever- Mauritania and Senegal WHO · 5 Nov 2025
Where it occurs
RVF is endemic in sub-Saharan Africa and the Arabian Peninsula. Outbreaks are often associated with periods of heavy rainfall and flooding, which create favorable conditions for mosquito breeding. Countries such as Mauritania, Senegal, Kenya, and Sudan have reported recurrent outbreaks.
- Rift Valley fever Wikipedia
- Rift Valley fever- Mauritania and Senegal WHO · 5 Nov 2025
Recent history
Since 1996, there have been 21 documented outbreaks of RVF, with notable events in Mauritania, Senegal, Kenya, and Sudan. The most recent outbreak occurred between September and October 2025 in Mauritania and Senegal, with 404 confirmed human cases and 42 deaths reported. This outbreak was associated with heavy rains and increased mosquito activity, highlighting the environmental factors that contribute to the spread of the disease.
- Rift Valley fever- Mauritania and Senegal WHO · 5 Nov 2025
What to watch
Key factors to monitor include environmental conditions such as heavy rainfall and flooding, which can lead to increased mosquito populations and higher risk of RVF outbreaks. Monitoring livestock health and implementing vaccination programs in endemic regions are crucial. Additionally, surveillance for human cases, especially among high-risk groups like farmers and veterinarians, is essential to prevent and control outbreaks.
- Rift Valley fever- Mauritania and Senegal WHO · 5 Nov 2025